Kazuo Mishima
Dados Biográficos
| ID | 7071952 |
|---|---|
| NOME | Kazuo Mishima |
| PRENOMES | Kazuo |
| SOBRENOME | Mishima |
| ASSINATURA | MISHIMA K |
| AFILIAÇÕES | Akita University |
| ORCID | 0000-0003-1182-1181 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 7 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 7 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2022 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Development, reliability, and validity of the quality of life scale for insomnia
The QOL-I demonstrated good reliability and validity and is expected to be a valuable tool for clinically assessing the QOL of patients with insomnia
Feasibility of a wrist-worn wearable device for estimating mental health status in patients with mental illness
A wrist-worn wearable device that measures PPG signals was feasible for use with patients with mental illness. Resting state HR and HRV could be used as an objective assessment of mental health status within a few days of measurement
Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic
We successfully created a DA for individuals with anxiety disorders who consider tapering BZD anxiolytics, which was acceptable for both patients and healthcare providers. Our DA was designed to assist patients and healthcare providers to involve decision-making about whether to taper BZD anxiolytics or not
Treatment strategy for insomnia disorder
Expert consensus indicates that orexin receptor antagonists and sleep hygiene education are recommended as first-line treatments in most clinical situations to treat insomnia disorder
Physicians’ attitudes toward hypnotics for insomnia
This study suggested that physicians believed ORA to be an effective and safe hypnotic and were compelled to prescribe benzodiazepine and non-benzodiazepine frequently, choosing efficacy over safety
A Comparison between Perceptions of Psychiatric Outpatients and Psychiatrists Regarding Benzodiazepine Use and Decision Making for Its Discontinuation
Background: Although long-term use of benzodiazepines and z-drugs (BZDs) is not recommended, little is known about the stakeholders’ perceptions. This study aimed to assess and compare the perceptions of BZD use and decision making regarding its discontinuation between psychiatric outpatients and psychiatrists. Methods: A cross-sectional survey was conducted. Results: Of 104 outpatients, 92% were taking hypnotics and 96% were taking anxiolytics f…
Attitudes and Difficulties Associated with Benzodiazepine Discontinuation
Long-term use of benzodiazepine receptor agonists (BZDs) may depend on clinicians' BZD discontinuation strategies. We aimed to explore differences in strategies and difficulties with BZD discontinuation between psychiatrists and non-psychiatrists and to identify factors related to difficulties with BZD discontinuation. Japanese physicians affiliated with the Japan Primary Care Association, All Japan Hospital Association, and Japanese Association …
Sem obras proeminentes nesta página.
Attitudes and Difficulties Associated with Benzodiazepine Discontinuation
Long-term use of benzodiazepine receptor agonists (BZDs) may depend on clinicians' BZD discontinuation strategies. We aimed to explore differences in strategies and difficulties with BZD discontinuation between psychiatrists and non-psychiatrists and to identify factors related to difficulties with BZD discontinuation. Japanese physicians affiliated with the Japan Primary Care Association, All Japan Hospital Association, and Japanese Association …
Feasibility of a wrist-worn wearable device for estimating mental health status in patients with mental illness
A wrist-worn wearable device that measures PPG signals was feasible for use with patients with mental illness. Resting state HR and HRV could be used as an objective assessment of mental health status within a few days of measurement
Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic
We successfully created a DA for individuals with anxiety disorders who consider tapering BZD anxiolytics, which was acceptable for both patients and healthcare providers. Our DA was designed to assist patients and healthcare providers to involve decision-making about whether to taper BZD anxiolytics or not
Treatment strategy for insomnia disorder
Expert consensus indicates that orexin receptor antagonists and sleep hygiene education are recommended as first-line treatments in most clinical situations to treat insomnia disorder
Physicians’ attitudes toward hypnotics for insomnia
This study suggested that physicians believed ORA to be an effective and safe hypnotic and were compelled to prescribe benzodiazepine and non-benzodiazepine frequently, choosing efficacy over safety
A Comparison between Perceptions of Psychiatric Outpatients and Psychiatrists Regarding Benzodiazepine Use and Decision Making for Its Discontinuation
Background: Although long-term use of benzodiazepines and z-drugs (BZDs) is not recommended, little is known about the stakeholders’ perceptions. This study aimed to assess and compare the perceptions of BZD use and decision making regarding its discontinuation between psychiatric outpatients and psychiatrists. Methods: A cross-sectional survey was conducted. Results: Of 104 outpatients, 92% were taking hypnotics and 96% were taking anxiolytics f…
Development, reliability, and validity of the quality of life scale for insomnia
The QOL-I demonstrated good reliability and validity and is expected to be a valuable tool for clinically assessing the QOL of patients with insomnia
Medicine (7 obras) · Psychiatry (7 obras) · Internal Medicine (6 obras) · Benzodiazepine (5 obras) · Psychology (5 obras) · Sleep and related disorders (5 obras) · Youth Substance Use and School Attendance (4 obras) · Discontinuation (3 obras) · Hypnotic (3 obras) · Insomnia (3 obras)